摘要
目的:分析二甲双胍与利拉鲁肽联合治疗2型糖尿病患者的临床效果。方法:收治2型糖尿病患者86例,平分两组。对照组给予二甲双胍治疗,研究组在此基础上给予利拉鲁肽治疗;对比两组血糖各项指标水平、不良反应发生率。结果:与对照组相比较,研究组患者治疗之后的血糖各项指标水平明显更优,差异有统计学意义(P<0.05)。结论:二甲双胍与利拉鲁肽联合治疗2型糖尿病患者的临床效果十分显著。
Objective:To analyze the clinical effect of metformin and liraglutide combined treatment in patients with type 2diabetes mellitus.Methods:86 patients with type 2 diabetes mellitus were selected.They were randomly divided into the two groups on average.The control group was treated with metformin.The research group received liraglutide treatment on the basis of the control group.The levels of blood glucose and the incidence of adverse reactions were compared between groups.Results:Compared with the control group,the levels of blood glucose after treatment in the study group was significantly better,and the difference was statistically significant(P<0.05).Conclusion:The clinical effect of metformin and liraglutide combined therapy in the treatment of patients with type 2 diabetes is very significant.
出处
《中国社区医师》
2017年第17期55-56,共2页
Chinese Community Doctors
关键词
二甲双胍
利拉鲁肽
2型糖尿病
Metformin
Liraglutide
Type 2 diabetes mellitus